Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.
- DOI
- 10.3389/fimmu.2022.974793
- Published
- 2022
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2022.974793,
title = {Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.},
author = {Hua H and He W and Chen N and He Y and Wu G and Ye F and Zhou X and Li Y and Ding Y and Zhong W and Teng L and Jiang W and Sheng Q},
year = {2022},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2022.974793},
url = {https://doi.org/10.3389/fimmu.2022.974793}
}RIS
TY - JOUR TI - Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy. AU - Hua H AU - He W AU - Chen N AU - He Y AU - Wu G AU - Ye F AU - Zhou X AU - Li Y AU - Ding Y AU - Zhong W AU - Teng L AU - Jiang W AU - Sheng Q PY - 2022 JO - Frontiers in immunology DO - 10.3389/fimmu.2022.974793 UR - https://doi.org/10.3389/fimmu.2022.974793 ER -
APA
H, H., W, H., N, C., Y, H., G, W., F, Y., X, Z., Y, L., Y, D., W, Z., L, T., W, J., & Q, S. (2022). Genomic and transcriptomic analysis of MSI-H colorectal cancer patients with targetable alterations identifies clinical implications for immunotherapy.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2022.974793
Source records
- pubmed · retrieved 2026-09-25T21:38:55.323Z